Skip to content

Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers

Family-Centered Intervention for the Transition to Living With Multiple Myeloma as a Chronic Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02129569
Enrollment
30
Registered
2014-05-02
Start date
2013-11-11
Completion date
2016-08-17
Last updated
2017-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma

Brief summary

This pilot clinical trial studies how well psychoeducational and behavioral strategies work in reducing distress and anxiety in patients with multiple myeloma and their family caregivers. Education and walking programs, may be able to reduce distress and anxiety and improve the well-being and quality of life of patients with multiple myeloma and their family caregivers. Understanding how different forms of education and support can promote emotional wellness may help nurse researchers find ways to improve services provided to patients and family members during cancer treatment.

Detailed description

PRIMARY OBJECTIVES: I. Evaluate the effect of the intervention, as compared to the control group, on emotional distress, the primary outcome, measured as anxiety in patients with multiple myeloma and their caregivers at the transition. II. Evaluate the effect, including the effect size, of the intervention, as compared to the control group, on activation for self-management, fatigue, depression, and health-related quality of life (HRQOL) in both patients and caregivers. III. Assess the feasibility, acceptability, and content integrity of the intervention in patients with multiple myeloma and their family caregivers. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants meet with a nurse in-person for approximately 30 minutes to receive information about strategies for cognitive self-management of distress and an individualized walking prescription to gradually increase their walking to 30 minutes per day, 5 times per week. Participants wear a pedometer for at least 3 consecutive days during weeks 1, 6, and 12. Participants are also contacted by the nurse via telephone at 1 and 3 weeks for supplemental counseling support. ARM II: Participants meet with a nurse in-person for approximately 20 minutes to receive National Cancer Institute (NCI) educational booklets and a link to the American Cancer Society (ACS) website. Participants are also contacted by the nurse via telephone at 1 and 3 weeks but the calls are primarily social in nature and do not include counseling support.

Interventions

OTHERPsychoeducational intervention

Receive information about strategies for cognitive self-management of distress

BEHAVIORALbehavioral intervention

Receive individualized walking prescription and wear pedometer

OTHERcounseling intervention

Receive supplemental counseling support over the phone

OTHEReducational intervention

Receive NCI educational booklets and a link to the ACS website

OTHERtelephone-based intervention

Receive calls that are primarily social in nature

OTHERquestionnaire administration

Ancillary studies

OTHERquality-of-life assessment

Ancillary studies

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Case Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* PATIENTS: Within 12 months of a new diagnosis of multiple myeloma or less than or equal to 2 cycles of treatment (all stages, with or without treatment) * PATIENTS: Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 * PATIENTS: Ambulatory with or without an assistive device (cane, walker) * PATIENTS: Cognitively intact, as evidenced by orientation to person, place, and time * PATIENTS: Ability to speak, read, and comprehend English * PATIENTS: Has an identified family caregiver who is willing to participate * CAREGIVERS: Any family member, who is identified by the patient as his/her caregiver * CAREGIVERS: ECOG performance status less than or equal to 2 * CAREGIVERS: Ambulatory with or without an assistive device (cane, walker) * CAREGIVERS: Cognitively intact, as evidenced by orientation to person, place, and time * CAREGIVERS: Ability to speak, read, and comprehend English * CAREGIVERS: Has an identified family member who is a patient * CAREGIVERS: Caregivers do not need to reside with the patient

Exclusion criteria

* PATIENTS: Have severe pain (pain score of 7 to 10 on a 0 to 10 scale) * PATIENTS: Are at high risk for bone fracture or who have a new fracture needing intervention, as determined by the physician * PATIENTS: Have untreated venous thrombosis, as determined by the physician * PATIENTS: Have a life expectancy of less than six months, as determined by the physician, and their caregivers * PATIENTS: Receiving active, concurrent treatment for a prior history of cancer (hormonal therapies allowed) * CAREGIVERS: Diagnosis of cancer and received cancer treatment within one year * CAREGIVERS: Medical condition that significantly affects their ability to walk * PATIENT or CAREGIVER: Is hearing impaired to the degree that they are unable to hear instructions via the phone * PATIENTS or CAREGIVER: Lives in a skilled nursing facility

Design outcomes

Primary

MeasureTime frameDescription
Change in emotional distress in patients measured as anxiety using the Patient-Reported Outcomes Measurement Information System (PROMIS)Baseline to up to 12 weeksA linear mixed model will be used and the model parameters will be estimated by the method of restricted maximum likelihood.

Secondary

MeasureTime frameDescription
Integrity of the intervention, assessed through fidelity monitoringUp to 12 weeks
Change in activation for self-management in patients using the Patient Activation Measure (PAM)Baseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.
Change in activation for self-management in caregivers using the PAMBaseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.
Change in fatigue in patients using the PROMISBaseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.
Change in fatigue in caregivers using the PROMISBaseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.
Satisfaction with the intervention assessed using an exit interview surveyAt 12 weeks
Change in depression in caregivers using the PROMISBaseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.
Change in HRQOL in patients using the PROMIS short form, Global HealthBaseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.
Change in HRQOL in caregivers using the PROMIS short form, Global HealthBaseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.
Feasibility of the intervention, assessed via attrition ratesUp to 12 weeks
Acceptability of the intervention, assessed via consent ratesUp to 12 weeks
Change in depression in patients using the PROMISBaseline to up to 12 weeksA linear mixed model will be used. If there are large numbers of missing values, the parameters will be estimated by utilizing the pattern mixture model. Should the change be non-linear, the model may be extended to allow for non-linearity. In the case of parametric model assumption violation, the generalized estimating equation approach may be used.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026